Your browser doesn't support javascript.
loading
Risk-reducing surgery in BRCA1/BRCA2 mutation carriers: Are there factors associated with the choice?
Manoukian, Siranoush; Alfieri, Sara; Bianchi, Elisabetta; Peissel, Bernard; Azzollini, Jacopo; Borreani, Claudia.
Afiliação
  • Manoukian S; Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Alfieri S; Clinical Psychlogy Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, Milan, Italy.
  • Bianchi E; Clinical Psychlogy Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, Milan, Italy.
  • Peissel B; Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Azzollini J; Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Borreani C; Clinical Psychlogy Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, Milan, Italy.
Psychooncology ; 28(9): 1871-1878, 2019 09.
Article em En | MEDLINE | ID: mdl-31264307
ABSTRACT

OBJECTIVE:

Female carriers of BRCA1/BRCA2 mutations (BRCAm) are at increased risk of developing breast and ovarian cancer. The main prevention options currently available consist in either clinical-radiological surveillance or risk-reducing surgery. This study investigated factors that might influence the choice of risk-reducing mastectomy (RRM) and/or salpingo-oophorectomy (RRSO) over surveillance in high-risk women.

METHODS:

One hundred twenty-eight BRCAm women, 75 (58.60%) cancer affected (C-A) and 53 (41.40%) cancer-unaffected (C-UN), completed a baseline questionnaire concerning socio-demographic factors, personal medical history, cancer family history, and psychological dimensions. Preferences about prevention strategies were evaluated after 15 months. Multivariate logistic regression was used to analyse the relationship between these factors and the choice of RRSO or RRM in the whole cohort and the choice of surgery (RRM and/or RRSO) in C-A and C-UN women.

RESULTS:

The analyses on the whole cohort highlighted factors associated with the choice of both RRM and RRSO ("cancer concern," "previous therapeutic mastectomy," and "number of cancer-affected family members"), but also a few specifically associated with either RRM (age) or RRSO ("health" and "energy" perception and "number of children"). Surgery was more likely to be chosen by C-A (76%) than C-UN women (34%). With the exception of "cancer concern," factors associated with the choice of surgery were different between C-A ("number of deaths for cancer in the family" and "feeling downhearted and blue") and C-UN ("number of children" and "health perception") women.

CONCLUSION:

This study highlights potential drivers underlying the choice of preventive surgery, which should be considered when supporting the decision-making process in these women.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias da Mama / Proteína BRCA1 / Proteína BRCA2 / Comportamento de Redução do Risco Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias da Mama / Proteína BRCA1 / Proteína BRCA2 / Comportamento de Redução do Risco Idioma: En Ano de publicação: 2019 Tipo de documento: Article